Business Standard

Pfizer to offer nearly two dozen low-cost products to poor nations

The products, which are widely available in the US and the European Union, include 23 medicines and vaccines that treat infectious diseases, some cancers and rare and inflammatory conditions

Pfizer

AP New York
Pfizer said Wednesday that it will provide nearly two dozen products, including its top-selling COVID-19 vaccine and treatment, at not-for-profit prices in some of the world's poorest countries.
The drugmaker announced the programme at the World Economic Forum's annual gathering in Davos, Switzerland, and said it was aimed at improving health equity in 45 lower-income countries. Most of the countries are in Africa, but the list also includes Haiti, Syria, Cambodia and North Korea.
The products, which are widely available in the US and the European Union, include 23 medicines and vaccines that treat infectious diseases, some cancers and rare and inflammatory conditions. Company spokeswoman Pam Eisele said only a small number of the medicines and vaccines are currently available in the 45 countries.
New York-based Pfizer will charge only manufacturing costs and minimal distribution expenses, Eisele said. It will comply with any sanctions and all other applicable laws.
Earlier this month, the head of the World Health Organization called on Pfizer to make its COVID-19 treatment more widely available in poorer countries. Pfizer has said its COVID-19 vaccine, Comirnaty, is already being provided to poorer counties at a not-for-profit rate through the US government, which buys the shots and then distributes them for free.
Comirnaty brought in nearly USD 37 billion in sales last year, and analysts expect the company's COVID-19 treatment Paxlovid to add almost $24 billion this year, according to the data firm FactSet.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 25 2022 | 2:40 PM IST

Explore News